Buyer: NHS EnglandSupplier: ASTRAZENECA UK LIMITED; Accord UK Ltd; Ascend Laboratories; Aspire Pharma Ltd; Aventis Pharma Ltd; CONSILIENT HEALTH (UK) LIMITED; CST PHARMA LIMITED; Camurus AB; Cipla (EU) Limited; Day Lewis Medical Ltd; EUMEDICA PHARMA LTD; Essential Pharma; Esteve Pharmaceuticals Limited; Flexipharm Austrading Ltd; Flynn Pharma Ltd; GLENMARK PHARMACEUTICALS EUROPE LIMITED; Grunenthal; Jannsen-Cilag Limited; LOGIXX PHARMA LIMITED; Lupin Healthcare (UK) Limited; MACARTHYS LABORATORIES LIMITED; MEDAC PHARMA LLP; MERCURY PHARMACEUTICALS LIMITED; MORNINGSIDE PHARMACEUTICALS LIMITED; MSN Laboratories Europe Limited; Merck Sharp & Dohme UK Ltd; NAPP PHARMACEUTICALS LIMITED; Neuraxpharm UK Ltd; Nordic Pharma Ltd; Norgine Pharmaceuticals Limited; Novartis Pharmaceuticals UK Ltd; ORPHALAN UK LTD; PFIZER LIMITED; RENASCIENCE PHARMA LIMITED; ROSEMONT PHARMACEUTICALS LTD; SANTEN UK LIMITED; SERB LTD; STIRLING ANGLIAN PHARMACEUTICALS LIMITED; SWEDISH ORPHAN BIOVITRUM LTD; SYNCHRONY (CNX THERAPEUTICS LIMITED); SYRI LIMITED; Selective Supplies Limited; Sun Pharma UK Ltd; TAKEDA UK LIMITED; THEA PHARMACEUTICALS LIMITED; THORNTON & ROSS LIMITED; Teva UK Limited; Unicorn Pharmaceuticals Ltd; Viatris UK Healthcare Ltd; ZENTIVA PHARMA UK LIMITED; Zydus Pharmaceuticals UK Ltd